4:19 PM
 | 
Sep 11, 2017
 |  BC Extra  |  Company News

Teva names new CEO after seven-month hunt

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA) jumped on Monday after naming Kåre Schultz president and CEO. Teva gained $3 (19%) to $18.50 in New York and NIS9.06 (17%) to NIS63.55 in Tel Aviv.

Teva has been seeking a new CEO since Erez Vigodman...

Read the full 208 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >